Maze Therapeutics

Translating human genetics insights into a pipeline of novel precision therapies for common diseases

a16z2019Active

What they do

Problem

Common diseases often lack effective treatments tailored to patients' genetic drivers.

Solution

Maze Therapeutics uses human genetics to discover and develop precision therapies targeting genetically validated disease pathways.

Who it's for

Clinicians and patients who need targeted treatments for common diseases (delivered via healthcare and pharmaceutical channels).

Charles Homcy

Sekar Kathiresan

Mark Daly

Stephen Elledge

Aaron D. Gitler

Jonathan S. Weissman